Global biopharmaceutical company Bristol Myers Squibb, based in Princeton, NJ, has earned the prestigious global CEO Cancer Gold StandardTM accreditation for its ongoing commitment to reduce cancer risk for employees and their family members around the world.
(June 29, 2020) – The CEO Cancer Gold Standard™, the employer-led health and wellness accreditation program of the CEO Roundtable on Cancer, is now helping more than seven million employees and their family members prevent and address cancer through workplace-based programming. This year, 18 Gold Standard employers mark their ten-year anniversary as Gold Standard employers, having maintained a strong commitment to the health of their employees and satisfying the latest, comprehensive requirements of the Gold Standard.
CARY, NC (June 16, 2020) Global biopharmaceutical company Bristol Myers Squibb, based in Princeton, NJ, has earned the prestigious global CEO Cancer Gold StandardTM accreditation for its ongoing commitment to reduce cancer risk for employees and their family members around the world.
Anne Arundel Medical Center has earned CEO Cancer Gold StandardTM accreditation for its work to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer (CEORT) today announced the appointment of K. Andrew Crighton, MD to serve as chief executive officer, beginning in January 2020. Dr. Crighton will succeed founding CEO, Martin J. Murphy, DMedSc, PhD, who will remain with the organization as a member of the board of directors and leader of several vital projects.
The CEO Roundtable on Cancer proudly announces the State of Colorado has earned CEO Cancer Gold Standard™ accreditation, recognizing Governor John W. Hickenlooper’s efforts to reduce the risk of cancer for state employees and covered family members.
The CEO Roundtable on Cancer Inc. honored Jean Becker, Ken Lee and Phil Porter, three leaders dedicated to cancer prevention and to speeding cancer research, with the 2018 Dr. Charles A. Sanders Life Sciences Award in recognition of their extraordinary collaboration with the CEO Roundtable on Cancer’s Life Sciences Consortium and its Project Data Sphere, LLC.
The CEO Roundtable on Cancer has accredited Aura Biosciences of Cambridge, MA — a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells — with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
Initiative realizes tremendous progress in making clinical trial data and resources more broadly available and accessible to the cancer research and care community
The CEO Roundtable on Cancer has accredited Pappas Capital, in Durham, NC, with CEO Cancer Gold StandardTM accreditation, recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer honored the U.S. Food and Drug Administration (FDA) with the 2017 Dr. Charles A. Sanders Life Sciences Award in recognition of their continued and expanded collaboration with the CEO Roundtable on Cancer’s Life Sciences Consortium and Project Data Sphere, LLC.
Through a grant from the Robert Wood Johnson Foundation (RWJF), outreach efforts are underway to encourage academic institutions to adopt the CEO Cancer Gold Standard, a no cost employer-led health and wellness initiative that recognizes exceptional workplaces committed to reducing the burden of cancer for their employees.
The CEO Roundtable on Cancer has accredited Cree in Durham, NC with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
CARY, NC (May 30, 2017) – The University of North Dakota has earned CEO Cancer Gold Standard™ re-accreditation for maintaining a strong commitment to the health of its employees and satisfying the comprehensive requirements of the Gold Standard for the past ten years.
CARY, N.C. (04/03/2017) The CEO Roundtable on Cancer has accredited LEERINK Partners LLC in Boston, MA with the CEO Cancer Gold StandardTM recognizing its efforts to reduce the risk of cancer for its employees and covered family members.
The CEO Roundtable on Cancer has accredited CVS Health (NYSE: CVS), the nation’s largest pharmacy innovation company, with the CEO Cancer Gold Standard, recognizing its efforts to reduce the risk of cancer for its employees and covered family members. The company earned the distinguished Gold Standard accreditation for taking actions in five key areas of health and wellness to fight cancer in the workplace, including: discouraging tobacco use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and providing access to quality care.
The CEO Roundtable on Cancer has elected Joaquin Duato of Johnson & Johnson to its Board of Directors.
The CEO Roundtable on Cancer presented the Robert Wood Johnson Foundation with the 2016 Dr. Charles A. Sanders Life Sciences Award in recognition of their innovative and collaborative work in the CEO Roundtable on Cancer’s Life Sciences Consortium.